Essential nutrients suppress inflammation by modulating key inflammatory gene expression

International Journal of Molecular Medicine

Volumn 22, Issue 6, 2008, Pages 731-741

  Ivanov, V ^a   Cha, J ^a   Ivanova, S ^a   Kalinovsky, T ^a   Roomi, M W ^a   Rath, M ^a   Niedzwiecki, Aleksandra ^a  

^a Dr Rath Research Institute   (United States)

Author keywords

BALB c mice; Cytokine; Inflammation; Macrophage U937

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ARGININE; ASCORBIC ACID; CATECHIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HESPERETIN; IBUPROFEN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LYSINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NARINGENIN; PROLINE; PROSTAGLANDIN E2; QUERCETIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DIET SUPPLEMENTATION; DOWN REGULATION; DRUG TARGETING; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUTRIENT MIXTURE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINES; DIETARY SUPPLEMENTS; DINOPROSTONE; GENE EXPRESSION; HUMANS; IBUPROFEN; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION FACTOR RELA; U937 CELLS;

EID: 65449182395     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000079     Document Type: Article

References (23)

1. Plutzky J: Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 88: 10K-15K, 2001.
2. Jatta K, Wagsater D, Norgren L, Stenberg B and Sirsjo A: Lipopolysaccharide-induced cytokine and chemokine expression in human carotid lesions. J Vasc Res 42: 266-271, 2005.
3. Opal SM and DePalo VA: Anti-inflammatory cytokines. Chest 117: 1162-1172, 2000.
4. Wong MM and Fish EN: Chemokines: attractive mediators of the immune response. Semin Immunol 15: 5-14, 2003.
5. Lawrence T, Gilroy DW, Colville-Nash PR and Willoughby DA: Possible new role for NF-kappa B in the resolution of inflammation. Nat Med 7: 1291-1297, 2001.
6. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ and Willoughby DA: Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5: 698-701, 1999.
7. Ahmed S, Wang N, Lalonde M, Goldberg VM and Haqqi TM: Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther 308: 767-773, 2004.
8. Jung WJ and Sung MK: Effects of major dietary antioxidant on inflammatory markers of RAW 264.7 macrophages. Biofactors 21: 113-117, 2004.
9. Kawaguchi K, Kikuchi S, Hasunuma R, Maruyama H, Hoshikawa T and Kumazawa Y: A citrus favonoid hesperidin suppresses infection-induced endotoxin shock in mice. Biol Pharm Bull 27: 679-683, 2004.
10. Fiebich BL, Lieb K, Kammerer N and Hüll M: Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia. J Neurochem 86: 173-178, 2003.
11. Kawaguchi K, Kikuchi S, Hasunuma R, Maruyama H, Ryll R and Kumazawa Y: Suppression of infection-induced endotoxin shock in mice by a citus flavanone naringin. Planta Med 70: 17-22, 2004.
12. Farrell S: Toxcity, acetaminophen. emedicine toxicity, acetaminophen 2006 http://emedicine.com/emerg/topic819.htm.
13. Cooke JP and Dzau VJ: Nitric oxide synthase: Role in the genesis of vascular disease. Annu Rev Med 48: 489-509, 1997.
14. Uhlmann D, Scommotau SH, Witzigmann H and Spiegel HU: Exogenous L-arginine protects liver microcirculation from ischemia reperfusion injury. Eur Surg Res 30: 175-184, 1998.
15. Fitzgerald GA: Coxibs and cardiovascular disease. N Engl J Med 351: 1709-1711, 2004.
16. Ghosh S, May MJ and Kopp EB: NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260, 1998.
17. Talalay P and Talalay P: The importance of using scientific principles in the development of medicinal agents from plants. Acad Med 76: 238-247, 2001.
18. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231: 232-235, 1971.
19. Mix KS, Mengshol JA, Benbow U, Vincenti MP, Sporn MB and Brinckerhoff CE: A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines. Arthritis Rheum 44: 1096-1104, 2001.
20. Rahusen FTJ, Weingold PS and Almekinders LC: Nonsteroidal anti-inflammatory drugs and acetaminophen in the treatment of an acute muscle injury. Am J Sports Med 32: 1856-1859, 2004.
21. Warner TD, Giuliana F, Vojnovic I, Bukasa A, Mitchell JA and Vane JR: Nonsteroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 96: 7563-7568, 1999.
22. Baldwin AS: The NF-.B and I.B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-681, 1996.
23. Vane J and Botting R: Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J 1: 89-96, 1987.